PEPTIDE

Men's / women's telehealth

Women's Telehealth Service — Type G

Jurisdiction: Australia-wideLast updated: 8 April 2026

Direct-to-consumer telehealth model targeting women's health and wellness — metabolic, hormonal, skin and weight-management.

Trust score

3.5 / 5
  • Medical oversight3.4 / 5
  • Transparency3.2 / 5
  • Access clarity4.2 / 5
  • Pricing clarity3.6 / 5
  • Support clarity3.5 / 5
  • Aftercare3.2 / 5

Strengths

  • Convenient access
  • Broader scope spanning multiple health areas
  • Some operators have strong women's health credentials

Concerns

  • Marketing pressure can dominate
  • Abbreviated medical assessments common
  • Aftercare often thin
  • Compounded preparations sometimes pushed outside lawful scope

Editorial review

Women's telehealth services follow a similar model to men's services but with broader scope — often spanning metabolic, hormonal, skin, and weight-management offerings under one roof. Strong examples invest in clinical structure and offer real ongoing care; weaker examples operate as marketing funnels.

Peptide-relevant offerings most often centre on GLP-1 agonists for chronic weight management, with adjacent skin and hormone-axis discussions. Compounded preparations sometimes appear, particularly in skin and HRT-adjacent contexts.

What to look for: women's health credentials of the medical team, real medical assessment (not just a self-report form), separation between health content and commercial offers, and willingness to decline patients where appropriate.

Compounds typically prescribed

  • GLP-1 agonists
  • Hormone-replacement adjacent care
  • Skin and aesthetics support

Typical eligibility

  • Adult women with relevant health concerns
  • Willing to complete the service's medical intake

Comparing models? Browse the full clinic hub.

See all clinic profiles